NUVATION BIO

Q: What industry does NUVATION BIO belong to?

NUVATION BIO is in the industry of: Pharmaceuticals , Healthcare

Q: What is NUVATION BIO competition?

NUVATION BIO top competitors include: NGM Bio , Micromet , Enliven Therapeutics , CANbridge Pharmaceuticals

Manufacturing · New York, United States · 159 Employees

View Company Info for Free

About

Headquarters

1500 Broadway Ste 1401, New York City, New York...

Phone Number

(332) 208-6102

Website

www.nuvationbio.com

Revenue

$93.5 Million

Stock Symbol

NUVB

Industry

Pharmaceuticals

Healthcare

Most Recent Scoops

Sep 10 2024

Open Position

Sep 6 2024

Open Position

NUVATION BIO is currently seeking a Regional Director, Various Roles. (Philadelphia, Pennsylvania, United States)

See all scoops

Highlights

$275M

Total Funding Amount

$275M

Most Recent Funding Amount

Number of Funding Rounds

View details

Who is NUVATION BIO

Founded in 2018 and located in New York City, Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates.Read more

Is this data correct?

View contact profiles from NUVATION BIO

Popular SearchesNuvation Bio IncNuvation BioThe NuVation CoNuVationNuvation CoSIC Code 28,283NAICS Code 32,325Ticker NYSE: NUVBShow more

NUVATION BIO Org Chart

Phone

Colleen Sjogren

Chief Commercial Officer

Phone

Is NUVATION BIO your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Click to see if NUVATION BIO had a recent Job posting/layoffs

Check out if NUVATION BIO is spiking on competitors!

Funding: Get notified immidiatlly once NUVATION BIO has new funding data

Earning: See what the market has to say on NUVATION BIO recently announced quarterly report

Check if NUVATION BIO has recently received funding, and reach out quickly before it becomes old news!

NUVATION BIO, which may be a good buyer, showed buying intent in Masked Content Topic

Website visits: Recent activity has been detected on your website

Product Launch: Get notified when NUVATION BIO launches new products

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Congratulate Masked Content for being promoted to Masked Content at NUVATION BIO

Recommended Actions

Introduce yourself to Masked Content, who has shown a strong intent to purchase lately

Find 2 more new buyers

Similar Companies to NUVATION BIO

Analyze insights from companies similar to NUVATION BIO and make strategic comparisons based on performance, financial data, growth and unique benchmarks.

See more companies

View Email Formats for NUVATION BIO

NUVATION BIO financials insights

Gather financial insights about NUVATION BIO, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

Graph showing recent funding, most recent acquisition, and main investor information for NUVATION BIO.

See All Financials Insights

NUVATION BIO Employee Growth Rate

Graph showing projected employee growth data for NUVATION BIO

View NUVATION BIO’s full employee growth data

Percentage of growth

1st year Mask

2nd year Mask

NUVATION BIO Tech Stack

A closer look at the technologies used by NUVATION BIO

See more technologies

Most Recent Scoops

Sep 10 2024

Open Position

Sep 7 2024

Open Position

Sep 6 2024

Open Position

NUVATION BIO is currently seeking a Regional Director, Various Roles. (Philadelphia, Pennsylvania, United States)

Sep 5 2024

Open Position

NUVATION BIO is currently seeking a Regional Director, Swim Center. (Las Vegas, Nevada, United States)

Aug 31 2024

Open Position

NUVATION BIO is currently seeking a Regional Director, Enterprise Sales. (Mississippi, United States)

See more scoops

NUVATION BIO News & Media

Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced the appointment of Philippe Sauvage as Chief Financial Officer (CFO). Mr. Sauvage brings over 20 years of global leadership experience in finance, operations, and commercialization within healthcare and biopharmaceutical organizations. Most recently, as Global Head of Operations and Access at Sanofi, he oversaw
Oct 7, 2024
www.businesswire.com
Positive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced positive pooled data from the pivotal Phase 2 TRUST-I and TRUST-II studies evaluating taletrectinib, an investigational next-generation ROS1 TKI. The findings will be highlighted in a poster presentation on September 14, 2024, at the European Society of Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain.
Sep 14, 2024
www.businesswire.com
Nuvation Bio to Present at the Cantor Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio, will present at the Cantor Global Healthcare Conference in New York, NY on Thursday, September 19, 2024, at 9:45 a.m. E.T. A live webcast of the presentation will be available on the Nuvation Bio website at https://investors.
Sep 9, 2024
www.businesswire.com
Nuvation Bio shareholders approve key proposals; leadership changes announced
Nuvation Bio shareholders approve key proposals; leadership changes announced
Sep 6, 2024
www.investing.com
Nuvation Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today reported financial results for the second quarter ended June 30, 2024, and provided a business update. “In the second quarter, we were pleased to share data at ASCO from TRUST-I, the pivotal study of taletrectinib in China, which although immature due to an early data cutoff, demonstrated taletrectinib’s efficacy, durabil
Aug 5, 2024
www.businesswire.com

Top Companies in United States

Frequently Asked Questions Regarding NUVATION BIO

Where is NUVATION BIO located?

NUVATION BIO's headquarters are located at 1500 Broadway Ste 1401, New York City, New York, 10036, United States

What is NUVATION BIO's phone number?

NUVATION BIO's phone number is (332) 208-6102

What is NUVATION BIO's stock symbol?

NUVATION BIO's stock symbol is NUVB

What is NUVATION BIO's official website?

NUVATION BIO's official website is www.nuvationbio.com

What is NUVATION BIO's Revenue?

NUVATION BIO's revenue is $93.5 Million

What is NUVATION BIO's SIC code?

NUVATION BIO's SIC: 28,283

What is NUVATION BIO's NAICS code?

NUVATION BIO's NAICS: 32,325

How many employees does NUVATION BIO have?

NUVATION BIO has 159 employees

What industry does NUVATION BIO belong to?

NUVATION BIO is in the industry of: Pharmaceuticals, Healthcare

What is NUVATION BIO competition?

NUVATION BIO top competitors include: NGM Bio, Micromet, Enliven Therapeutics, CANbridge Pharmaceuticals

What companies has NUVATION BIO acquired?

NUVATION BIO has acquired the companies: AnHeart Therapeutics

What technology does NUVATION BIO use?

Some of the popular technologies that NUVATION BIO uses are: Q4, WooCommerce, WordPress.org, reCAPTCHA

How do I contact NUVATION BIO?

NUVATION BIO contact info: Phone number: (332) 208-6102 Website: www.nuvationbio.com

What does NUVATION BIO do?

What are NUVATION BIO social media links?

NUVATION BIO Linkedin page

How much funding has NUVATION BIO raised to date?

NUVATION BIO has raised $275 Million in 1 funding round

When was the last funding round for NUVATION BIO?

NUVATION BIO closed its last funding round on Oct 28, 2019 with the amount of $275 Million

Who invested in NUVATION BIO?

NUVATION BIO has 12 investors including Aisling Capital, EDBI, Pavilion Capital and The Baupost Group.

Is NUVATION BIO a public company?

Yes, NUVATION BIO is a public company and is traded under the symbol NUVB

See more information about NUVATION BIO

NUVATION BIO Latest Hires and Their Positions

NUVATION BIO is expanding and recently hired new employees. Here are the latest additions to the team.

Gopi Chari

Director

Joined Sep 1, 2024

Phone

Heidi Hurn

Senior Director, Access Strategy

Joined Sep 1, 2024

Phone

Jennifer Saul-Klein

Executive Director, Legal

Joined Aug 1, 2024

Phone

Nikki Foeller

Executive Director, Regulatory Advertising, Promotion & Labeling

Joined Aug 1, 2024

Phone

Sell Smarter. Win Faster.

Level up your game to ZoomInfo Copilot, intuitive AI that turns your data and high-quality ZoomInfo data into an unfair advantage for your go-to-market teams.